Scott C. Woller, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism (NCT06232551) | Scott C. Woller, MD | 2024-06-01 |
| Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome (NCT02295475) | Scott C. Woller, MD | 2014-12-10 |
Track Scott C. Woller, MD automatically
Every clearance here is in the API, with alerts when new ones post.